Nongfu Spring IPO: Trading Debut
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
463 Views
Nongfu Spring IPO Trading Update - Strong Subscription Levels, in a League of Its Own
Nongfu Spring (NON HK) is looking to raise up to US$1bn in its Hong Kong listing. The company is the market leader in packaged drinking water in...
887 Views
Dali Foods (3799 HK): Story Remains Unexciting, Retain SELL
Revenue in H120 at Dali Foods Group (3799 HK) declined by 8.7% YoY, but margins were relatively stable and the company managed to report net EPS of...
243 Views
Nongfu Spring IPO: Valuation Insights
Nongfu Spring (9633 HK) is a leader in the packaged drinking water and beverage business in China. Nongfu had the leading market share in the...
864 Views
Nongfu Spring IPO - Not Cheap by Any Measure but Is a Quality Name
Nongfu Spring (NON HK) is looking to raise up to US$1bn in its Hong Kong listing. The company is the market leader in packaged drinking water in...
732 Views